Welcome to LookChem.com Sign In|Join Free
  • or
[1,1'-Biphenyl]-4-carboxylic acid, hexahydro-2-oxo-4-(3-oxo-4-phenoxy-1-butenyl)-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3aα,4α(E),5β,6aα]](9CI) is a complex organic ester compound derived from the esterification of [1,1'-Biphenyl]-4-carboxylic acid and hexahydro-2-oxo-4-(3-oxo-4-phenoxy-1-butenyl)-2H-cyclopenta[b]furan-5-yl. It is characterized by its unique molecular structure and properties, which make it suitable for various chemical and pharmaceutical applications. [1,1'-Biphenyl]-4-carboxylicacid, hexahydro-2-oxo-4-(3-oxo-4-phenoxy-1-butenyl)-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3aα,4α(E),5β,6aα]](9CI) is also known as [3aR-[3aα,4α(E),5β,6aα]]and is registered under the Chemical Abstracts Service (CAS) number 123948-87-5.

79171-99-6

Post Buying Request

79171-99-6 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

79171-99-6 Usage

Uses

Used in Chemical Industry:
[1,1'-Biphenyl]-4-carboxylic acid, hexahydro-2-oxo-4-(3-oxo-4-phenoxy-1-butenyl)-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3aα,4α(E),5β,6aα]](9CI) is used as a key intermediate in the synthesis of various specialty chemicals and pharmaceuticals. Its unique structure and properties enable it to serve as a building block for the development of new compounds with specific functionalities and applications.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, [1,1'-Biphenyl]-4-carboxylic acid, hexahydro-2-oxo-4-(3-oxo-4-phenoxy-1-butenyl)-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3aα,4α(E),5β,6aα]](9CI) is utilized as a precursor for the synthesis of novel drug candidates. Its unique molecular structure allows for the development of compounds with potential therapeutic applications, such as in the treatment of various diseases and disorders.
Used in Drug Delivery Systems:
[1,1'-Biphenyl]-4-carboxylic acid, hexahydro-2-oxo-4-(3-oxo-4-phenoxy-1-butenyl)-2H-cyclopenta[b]furan-5-yl ester, [3aR-[3aα,4α(E),5β,6aα]](9CI) can also be employed in the design and development of drug delivery systems. Its unique properties may enable the creation of innovative formulations that improve the bioavailability, stability, and targeted delivery of therapeutic agents, ultimately enhancing their efficacy and safety.

Check Digit Verification of cas no

The CAS Registry Mumber 79171-99-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,1,7 and 1 respectively; the second part has 2 digits, 9 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 79171-99:
(7*7)+(6*9)+(5*1)+(4*7)+(3*1)+(2*9)+(1*9)=166
166 % 10 = 6
So 79171-99-6 is a valid CAS Registry Number.

79171-99-6Relevant academic research and scientific papers

He fluorine front row element intermediate preparation method (by machine translation)

-

Paragraph 0049; 0050; 0051; 0052; 0053; 0054, (2018/05/16)

The invention discloses he fluorine front row element intermediate, i.e. formula 5 compound preparation method, including the use of biphenyl formyl protected Corey lactone as raw materials, through oxidation, HWE connected side chain, fluorinated, hydrolysis of deprotection step. Preparation method of this invention has the operability is strong, stable process, intermediates for the preparation of white powder, good stability. (by machine translation)

N-(Methanesulfonyl)-16-phenoxyprostaglandincarboxamides: Tissue-Selective, Uterine Stimulants

Schaaf, Thomas K.,Bindra, Jasjit S.,Eggler, James F.,Plattner, Jacob J.,Nelson, A. James,et al.

, p. 1353 - 1359 (2007/10/02)

In an effort to develop tissue-selective prostaglandin analogues resistant to the metabolic inactivating pathways of the natural materials, hybrid compounds modified both at C-1 with a sulfonimide moiety and in the n-amylcarbinol side chain with substituted phenoxy groups were synthesized and evaluated in a variety of in vitro and in vivo models.Several of these analogues exhibited potent, tissue-selective, uterine stimulant activity, a finding subsequently confirmed in clinical studies with one member of this series, N-(methanesulfonyl)-16-phenoxy-ω-tetranor-PGE2-carboxamide (CP-34089/ZK-57671, sulprostone).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 79171-99-6